{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreidziotab4zhyivlf62x5tkpxtbnj5m6nn6k6fbk25lyz4uhp3c3ma",
    "uri": "at://did:plc:pmmp7irwts7faw56jdxk3idc/app.bsky.feed.post/3mobi24iukcx2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreigvdwpfcscxkl4lhz62m4ghxafjuocbrcjg3tp3jdnwdslzsxuwxu"
    },
    "mimeType": "image/jpeg",
    "size": 410285
  },
  "path": "/news/2026-06-semaglutide-linked-bone-fracture.html",
  "publishedAt": "2026-06-14T14:50:01.000Z",
  "site": "https://medicalxpress.com",
  "textContent": "In people with type 2 diabetes, semaglutide was associated with a 15% reduction in bone fractures and greater weight loss compared with other anti-obesity medications, according to a study presented at ENDO 2026, the Endocrine Society's annual meeting in Chicago.",
  "title": "Semaglutide linked to lower bone fracture risk"
}